Trial reportBMC palliative care2026
Evaluating virtual reality for anxiety reduction in children and adolescents with life-limiting conditions: a randomized pilot study.
Trial report in BMC palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundChildren and adolescents with life-limiting conditions (LLCs) often face distressing medical procedures, prolonged hospital stays, and other challenges, leading to heightened anxiety and psychological distress. To address these symptoms, psychological interventions using modern technologies like immersive virtual reality are recommended alongside traditional treatments. While virtual reality (VR) has shown promise in reducing distress in various pediatric groups, its use in pediatric palliative care (PPC) is still emerging. The aim of this study was to assess the feasibility, acceptability and effectiveness of experiential VR intervention and compare it with a second distraction method in the form of a video in a population of pediatric patients with LLC.
methodsThis pilot randomized control trial used a crossover design with a pre- and post- intervention assessment of anxiety, fear, and pain using standardized scales. Post-session patient-reported data were also collected using supplementary items. A total of eighteen pediatric patients (8 girls, 11-17 years of age;10 boys, 10 - 17 years of age) participated in the study, randomized into two groups. The experimental group (N = 10) received VR in both sessions, while the control group (N = 8) experienced a passive video in the first session, followed by VR in the second. Given the characteristics of the sample, non-parametric statistical analyses were conducted using the Mann-Whitney U test and Wilcoxon signed rank test.
resultsThe findings showed that VR distraction produced a statistically significant reduction in anxiety on all three occasions it was administered across both groups (experimental group: p = 0.028, r = 0.773; p = 0.049, r = 1.000; control group: p = 0.028, r = 0.905), demonstrating a consistent effect across the sample. Video distraction showed a trend toward anxiety reduction that did not reach statistical significance (p = 0.091), while producing a significant reduction in pain (p = 0.027). Among participants who received both interventions, VR was rated as significantly more enjoyable than video distraction (p = 0.036, r = -1.00). Most participants wanted to be distracted during the procedure (91%), felt that it decreased their anxiety (73%), found the VR system easy to use (96%), and wanted to use it again in future care (88%).
conclusionsThese exploratory findings from a pilot RCT provide preliminary evidence that VR distraction may serve as a feasible, acceptable, and potentially efficacious complementary approach for managing anxiety in children and adolescents with life-limiting conditions. While video distraction produced broadly comparable outcomes across measures, a differential pattern was observed for the predefined primary outcome of anxiety, which warrants confirmation in a future adequately powered trial. These findings highlight the potential of distraction-based interventions to provide meaningful therapeutic benefit in this population. The significantly higher enjoyment ratings for VR and its strong acceptability further support its potential clinical value in pediatric palliative care, where positive experience and engagement are central to quality of life. Nevertheless, the practical burden of implementation and associated costs require further investigation before definitive recommendations can be made.
trial registrationThe study was registered retrospectively 8.1. 2025 (ISRCTN50308167).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.